|
|
|
|
| www.kardio.ch |
 Editorial |
|
| Lüscher TF, Hellermann JP. Von den kardiovaskulären Risikofaktoren zum Global Risk Assessment: confused at a higher level oder wirklicher Fortschritt? [167] |
 |
Proceedings Basel 2004 |
|
| Carrel T, Englberger L. Coronary revascularisation in diabetics: surgical aspects [172] |
|
Originalarbeit |
|
| Romanens M, Berger DC, Battegay EJ. Predictive value of clinical risk assessment tools and guidelines for 10-year coronary heart disease risk in practice-based primary care [180] |
|
Case report |
|
| Windecker S, Meier B. Impella assisted high risk percutaneous coronary intervention [187] |
|
Das neue Medikament |
|
| Brockes C, Erne P. Nebivolol: hochselektiver B1-Rezeptorenblocker mit NO-modulierender Vasodilatation [190] |
|
Das interessante EKG |
|
| Buchholz S, Herren T. Apikale hypertrophe Kardiomyopathie - vom EKG zur Diagnose [204] |
|
Images in cardiovascular medicine |
|
| TrigoTrindade P, Didier D, Friedli B, Beghetti M, Aggoun Y. Collatérales veineuses systémiques après dérivation cavo-pulmonaire totale [207] |
|
Mitteilungen der Fachgesellschaften |
|
| Carrel T, Oechslin E, Payot M, Trigo-Trindade P. Jahresbericht 2003 der Arbeitsgruppe WATCH (Working Group for Adults and Teenagers with Congenital Heart Disease) der SGK [209] |
|
|
Copyright © 2005 EMH Swiss Medical Publishers Ltd. |
Top